Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion

Combination therapy for a stable and long term engraftment using specific protocols for T/B cell depletion

US Patent 11504399 · Granted Nov 22, 2022

Estimated economic value: $40,538,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Genetically modified anti-third party central memory T cells and use of same in 2025
Veto cells generated from memory T cells2025
Veto cells generated from memory T cells2025
Anti third party central memory t cells, methods of producing same and use of sa2024
Anti third party central memory t cells, methods of producing same and use of sa2024
Genetically modified anti-third party central memory T cells and use of same in 2023
Veto cells generated from memory T cells2023
Veto cells generated from memory T cells2023
Genetically modified veto cells and use of same in immunotherapy2023
Genetically modified veto cells and use of same in immunotherapy2023
Combination therapy for a stable and long term engraftment2022
Combination therapy for a stable and long term engraftment2022